These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 29080529

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Preparation of Concentrated Chitosan/DNA Nanoparticle Formulations by Lyophilization for Gene Delivery at Clinically Relevant Dosages.
    Veilleux D, Nelea M, Biniecki K, Lavertu M, Buschmann MD.
    J Pharm Sci; 2016 Jan; 105(1):88-96. PubMed ID: 26852843
    [Abstract] [Full Text] [Related]

  • 3. Purification and Surface Modification of Chitosan-based Polyplexes Using Tangential Flow Filtration and Coating by Hyaluronic Acid.
    Tavakoli Naeini A, Alameh MG, Soliman OY, Lavertu M.
    J Pharm Sci; 2022 Oct; 111(10):2857-2866. PubMed ID: 35640731
    [Abstract] [Full Text] [Related]

  • 4. Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer.
    Zhang W, Xu W, Lan Y, He X, Liu K, Liang Y.
    Int J Nanomedicine; 2019 Oct; 14():5287-5301. PubMed ID: 31406460
    [Abstract] [Full Text] [Related]

  • 5. Factors influencing polycation/siRNA colloidal stability toward aerosol lung delivery.
    Steele TW, Zhao X, Tarcha P, Kissel T.
    Eur J Pharm Biopharm; 2012 Jan; 80(1):14-24. PubMed ID: 21924355
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gene silencing activity of siRNA polyplexes based on thiolated N,N,N-trimethylated chitosan.
    Varkouhi AK, Verheul RJ, Schiffelers RM, Lammers T, Storm G, Hennink WE.
    Bioconjug Chem; 2010 Dec 15; 21(12):2339-46. PubMed ID: 21049986
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Natural Polysaccharides for siRNA Delivery: Nanocarriers Based on Chitosan, Hyaluronic Acid, and Their Derivatives.
    Serrano-Sevilla I, Artiga Á, Mitchell SG, De Matteis L, de la Fuente JM.
    Molecules; 2019 Jul 15; 24(14):. PubMed ID: 31311176
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS, Yawata T, Honke K.
    Eur J Pharm Sci; 2014 Feb 14; 52():48-61. PubMed ID: 24178005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.